Interface Consultation Services, PLLC

Evidence-based technique gains new respect as a valuable clinical tool. John Battaglia, MD Medical director, Program of Assertive Community Treatment, clinical associate professor, department of psychiatry, University of Wisconsin Medical School, Madison, WI Supportive psychotherapy began as a second-class treatment whose only operating principle was “being friendly” with the patient ( Box ). 1 Critics called it “simple-minded” 2 and sniffed, “if it is supportive, it is not therapy…if it is therapy, it is not supportive.” 3 Since its lowly beginning, however, supportive psychotherapy has been proven highly effective, and clinicians have developed operating principles... More

Discovering Our True Nature - Online Radio Show with Host Branden Cohen (click on link to listen to recent shows... Join Branden for his weekly internet radio show on Tuesday at 1pm or go to link above for live or achived shows. Each begins with a guided meditation and Branden welcomes guests and callers to share their personal experiences and ask questions. The show explores a variety of psychological and spiritual topics. Branden Cohen is a MA Clinical Psychologist. email him at brandencohen@hughes.net This week show and guest talk about addiction and ways to heal the most difficult of addictions and the heart.contact us at... interface_consultation@comcast.net

Provided by: Canadian Press Written by: ANNE-MARIE TOBIN Jun. 4, 2007 TORONTO (CP) - Older adults who suffer dementia and are given antipsychotic drugs have a slightly higher risk of death than those who aren't prescribed these medications, a large Canadian study suggests. And the older variety of antipsychotics - known as conventional agents - seems to be associated with a higher risk of death than newer atypical antipsychotics, researchers said in the study of Ontario patients, published Tuesday in the journal Annals of Internal Medicine. The study builds on previous research that led to warnings in the spring of 2005 from Health Canada and the U.S. Food and Drug Administration on atypical antipsychotics and dementia. Conventional antipsychotic drugs include chlorpromazine (brand names Largactil and Thorazine) and haloperidol (brand name Haldol). Examples of atypical antipsychotics are olanzapine, risperidone and quetiapine (brand names Zyprexa, Risperdal and Seroquel, respective